Supplementary Figure S6 from IL4/IL13 Inhibition via Dupilumab Reduces Malignant T-cell Proliferation and Promotes Antitumor Immunity in Sézary Syndrome
Abstract
Figure S6.TranscriptionalprofileofSSmyeloidcellsfollowinganti-IL13treatment exvivo.
Fields of Study & Subjects
Cutaneous lymphoproliferative disorders research
Dermatology and Skin Diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Publication date
- 3 February 2026